Skip to main content

Non-peptide inhibitors of dpp iv and type ii diabetes

Objective

The inhibition of DPP IV is a validated target in anti-type II diabetic therapy. Existing inhibitors suffer from poor chemical stability or poor selectivity and will be optimised by substituting an amide group for a fluoroolefin group

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

UNIVERSITAIRE INSTELLING ANTWERPEN - UNIVERSITEIT ANTWERPEN
Address
Universiteitsplein 1
2610 Wilrijk (Antwerpen)
Belgium